OnLux: Relief At The Speed of Light
OnLux and Clinical Research
Breakthrough Clinical Study Validates OnLux
At the 2024 Annual Meeting of The Clinical Orthopaedic Society, a groundbreaking study was presented highlighting the clinical effectiveness of OnLux. The study’s findings were showcased in the official E-poster, which you can find below. To access the full study, please click the link below.
Clinical Study Highlights: Proving OnLux's Efficacy
The recent study conducted at SUNY Upstate Medical University focused on three distinct cases that showcase the versatility and effectiveness of OnLux RILT therapy:
- Case 1: 50-year-old male with symptomatic discoid meniscus
- Case 2: 46-year-old male with symptomatic L3 disc herniation
- Case 3: 18-year-old collegiate baseball player with right disabling shoulder pain
In each case, traditional treatment options had failed to provide significant relief. The introduction of OnLux Red Light Therapy marked a turning point in their recovery journeys.
Clinical Study Highlights: Proving OnLux's Efficacy
The recent study conducted at SUNY Upstate Medical University focused on three distinct cases that showcase the versatility and effectiveness of OnLux RILT therapy:
- Case 1: 50-year-old male with symptomatic discoid meniscus
- Case 2: 46-year-old male with symptomatic L3 disc herniation
- Case 3: 18-year-old collegiate baseball player with right disabling shoulder pain
In each case, traditional treatment options had failed to provide significant relief. The introduction of OnLux Red Light Therapy marked a turning point in their recovery journeys.
Key Findings of the Study
These results underscore the potential of OnLux as a game-changing solution for patients seeking alternatives to conventional orthopedic treatments.
- Significant improvement within 4-6 weeks of treatment
- Sustained relief even after discontinuing Red Light Therapy treatments
- Near-complete resolution of symptoms in all three cases
- No adverse effects reported throughout the study
OnLux participated in a clinical study submitted for publication in Q4 2024.
This study adds to the growing body of research on light therapy’s potential role in reducing pain, inflammation, and improving healing for musculoskeletal injuries.
We look forward to posting updates on this website once the study is released.
OnLux: Revolutionizing Orthopedic Injury Management with Red and Infrared Light Therapy
The Power of Light: Understanding RILT Technology
At the heart of OnLux’s revolutionary approach lies the science of Red and Infrared Light Therapy (RILT). This non-invasive treatment harnesses the healing power of specific light wavelengths to penetrate deep into tissues, promoting cellular regeneration and reducing inflammation. The OnLux device utilizes a patent-pending combination of four different wavelengths:
- Blue (470nm): Known for its antimicrobial properties
- Red (660nm): Stimulates collagen production and tissue repair
- Near-Infrared (830nm): Enhances cellular energy production
- Far-Infrared (950nm): Promotes deep tissue heating and increased circulation
This unique blend of wavelengths creates a synergistic effect, maximizing the therapeutic benefits for users suffering from various orthopedic conditions.
OnLux is an FDA-registered infrared heating device. It operates within the infrared wavelength spectrum as defined by the FDA (700nm to 50,000nm).
PDAC approved OnLux as an HCPCS billing code of E0221 (infrared heating pad system), which is maintained by CMS and falls under Heat, Cold, and Light Therapies.
For more information visit the PDAC page.
Disclaimer: The following statements have not been evaluated by the FDA.
While operating within the FDA-defined infrared spectrum, OnLux primarily functions as a Photobiomodulation (PBM) therapeutic device, with secondary benefits of gentle infrared heat**.**
A recent study by Dr. Kevin Setter confirms OnLux exhibits characteristics consistent with PBM devices:
- Wavelength Spectrum: OnLux utilizes red and near-infrared wavelengths (660nm, 830nm, and 950nm), commonly employed and extensively researched in PBM therapy. Research, such as Hamblin & Huang (2009), supports the efficacy of these wavelengths in modulating biological tissues.
- Power Output: Operating at a power density between 12.6 and 14.88 mW/cm², OnLux aligns with typical PBM device parameters.
- Therapeutic Intent: The study supports that OnLux is primarily designed to influence cellular activity, mitigate pain, reduce inflammation, and accelerate tissue repair. Secondary benefits include gentle warmth for improved blood flow and muscle relaxation.
Experience the Power of Dual Therapy
Our innovative LED-based body wraps harness the combined benefits of Photobiomodulation (PBM) – a therapy using specific wavelengths of light to stimulate cellular function – and soothing infrared heat, a type of radiant heat that warms objects directly, to deliver a holistic approach to wellness. Designed to anatomically fit various joints, our wraps emit a precise blend of four wavelengths (470nm, 660nm, 830nm, and 950nm) at a gentle output of 12.6 to 14.88 mW/cm².
This technology penetrates deep into tissues to optimize oxygenated blood flow, reduce inflammation, and alleviate pain.
Key Benefits:
- Targeted Pain Relief: Soothe aching muscles and joints with our device’s penetrating infrared heat, combined with the anti-inflammatory benefits of PBM therapy.
- Enhanced Circulation: Increase blood flow and oxygen delivery to your tissues.
- Reduced Inflammation: Target inflammation at its source with our device’s powerful combination of light and heat therapies.
- Personalized Relief: Uniquely designed for individual joints.
- Dual Action Therapy: Combines PBM and infrared heat for optimized results.
- Comfortable Experience: Offers a simple “one-touch” solution that delivers soothing and effective treatment.
Discover the difference our precision wraps can make in managing everyday discomfort and enhancing overall well-being. Experience the future of pain relief today.
Disclaimer: OnLux is not intended to diagnose, cure, or prevent any disease. Consult with a healthcare professional for advice prior to using any phototherapy device.
OnLux: Targeted Light Therapy For Relief (utilizes LEDs)
Light therapy uses specific wavelengths of light to improve well-being. OnLux utilizes a targeted combination of red, near-infrared, and blue LED light to deliver potential benefits like improved blood flow, reduced inflammation, and pain relief.
Improved Blood Flow To Optimize Recovery
Light therapy, using specific wavelengths like red and near-infrared, has been studied for its potential to improve blood flow, which may contribute to faster healing and pain relief. Good blood flow is essential for this process, as it helps deliver oxygen and nutrients to tissues and remove waste products. Robust research in this area is ongoing to fully understand the effectiveness of these therapies.
